Warning! GuruFocus detected
3 Severe warning signs
with 52Q.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Magnasense AB
ISIN : SE0014401121
Share Class Description:
FRA:52Q: Ordinary SharesCompare
Compare
Traded in other countries / regions
MAGNA.Sweden52Q.GermanyAEGBF.USA IPO Date
2020-07-03Description
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -1.19 | |||||
Debt-to-Equity | -1.14 | |||||
Debt-to-EBITDA | -1.17 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 48.2 | |||||
3-Year EPS without NRI Growth Rate | 40.8 | |||||
3-Year FCF Growth Rate | 59.7 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.63 | |||||
9-Day RSI | 62.16 | |||||
14-Day RSI | 60.11 | |||||
3-1 Month Momentum % | 110.39 | |||||
6-1 Month Momentum % | -30.17 | |||||
12-1 Month Momentum % | -71.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.32 | |||||
Quick Ratio | 0.32 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -48.9 | |||||
Shareholder Yield % | -71 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -106.41 | |||||
ROIC % | -86.63 | |||||
3-Year ROIIC % | -11.41 | |||||
ROC (Joel Greenblatt) % | -1466.99 | |||||
ROCE % | -117.74 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -1.74 | |||||
EV-to-EBITDA | -1.74 | |||||
EV-to-FCF | -2.27 | |||||
Earnings Yield (Greenblatt) % | -57.55 | |||||
FCF Yield % | -125.83 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Magnasense AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.101 | ||
Beta | 1.22 | ||
3-Year Sharpe Ratio | -0.55 | ||
3-Year Sortino Ratio | -0.94 | ||
Volatility % | 172.06 | ||
14-Day RSI | 60.11 | ||
14-Day ATR (€) | 0.00132 | ||
20-Day SMA (€) | 0.015805 | ||
12-1 Month Momentum % | -71.78 | ||
52-Week Range (€) | 0.0045 - 0.0725 | ||
Shares Outstanding (Mil) | 84.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Magnasense AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Magnasense AB Stock Events
Event | Date | Price (€) | ||
---|---|---|---|---|
No Event Data |
Magnasense AB Frequently Asked Questions
What is Magnasense AB(FRA:52Q)'s stock price today?
The current price of FRA:52Q is €0.02. The 52 week high of FRA:52Q is €0.07 and 52 week low is €0.00.
When is next earnings date of Magnasense AB(FRA:52Q)?
The next earnings date of Magnasense AB(FRA:52Q) is 2025-05-16 Est..
Does Magnasense AB(FRA:52Q) pay dividends? If so, how much?
Magnasense AB(FRA:52Q) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |